Skip to main content
In stock | Targeted Therapy

Imetelstat

Oncology Type Hematologic (MDS)
Drug Class / Mechanism Oligonucleotide Telomerase Inhibitor (first-in-class)
No Image
Description

Imetelstat is classified as an Oligonucleotide Telomerase Inhibitor (first-in-class), sourced for use within our Targeted Therapy portfolio. Reach out to our team for full regulatory documentation, pricing, and current availability.

Therapeutic Category Targeted Therapy
Oncology Type Hematologic (MDS)

Send Inquiry

Submit your details to get a formal quote for this product.

Step 1 of 3